Yasuhisa Terao 研究室

主宰者：Yasuhisa Terao

順天堂大学・Juntendo University Hospital

AI 要約（直近 5 年の研究成果）

要約はまだ生成されていません。

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

外部リンク

研究成果（85 件）

[2026] Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review
DOI: https://doi.org/10.12659/ajcr.952931
[2026] Supplementary Figure S7 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705001
[2026] Supplementary Table S8 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704941
[2026] Supplementary Table S11 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704968
[2026] Supplementary Table S6 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704947
[2026] Supplementary Figure S10 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705034
[2026] Supplementary Table S5 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704950
[2026] Supplementary Table S3 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704956
[2026] Supplementary Figure S3 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705025
[2026] Supplementary Figure S6 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705007

続きを表示（残り 75 件）

[2026] Supplementary Figure S8 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704995
[2026] Supplementary Figure S1 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705040
[2026] Metabolomic and transcriptomic analyses identify metabolic alterations and immune suppression in ovarian cancer
DOI: https://doi.org/10.1038/s41598-026-38014-8
[2026] Supplementary Figure S5 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705013
[2026] Supplementary Figure S4 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705019
[2026] Data from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.c.8542095
[2026] Time lag between functional and structural lymphatic changes after lymphadenectomy: Insights from ICG lymphography and lymphatic ultrasound
DOI: https://doi.org/10.1371/journal.pone.0345408
[2026] Figure 1 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705070
[2026] Figure 5 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705055
[2026] Figure 6 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705052
[2026] Supplementary Descriptions from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705046
[2026] Figure 3 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705061
[2026] Supplementary Table S2 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704962
[2026] Supplementary Table S7 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704944
[2026] Supplementary Table S4 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704953
[2026] Supplementary Table S9 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704938
[2026] Figure 4 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705058
[2026] Supplementary Table S1 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704980
[2026] Supplementary Figure S9 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704989
[2026] Supplementary Figure S2 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705031
[2026] Supplementary Table S10 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32704974
[2026] Figure 2 from Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges
DOI: https://doi.org/10.1158/2767-9764.32705064
[2025] Optimizing dwell time weight for interstitial needles in intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with organ sparing using the inverse planning technique
DOI: https://doi.org/10.1093/jrr/rraf025
[2025] Novel anti-ITGA4 monoclonal antibody induces cell death via large pore formation in NK/T-cell lymphoma cells
DOI: https://doi.org/10.1038/s41598-025-32892-0
[2025] Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery
DOI: https://doi.org/10.1093/bjrcr/uaaf061
[2025] Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study
DOI: https://doi.org/10.1007/s10147-025-02926-8
[2025] A Survey of Current Practice and Perspectives on Lymphadenectomy in Minimally Invasive Surgery for Endometrial Cancer in Japan
DOI: https://doi.org/10.1111/jog.70138
[2025] Cell‐Free and Concentrated Ascites Reinfusion Therapy ( <scp>CART</scp> ) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study
DOI: https://doi.org/10.1111/1744-9987.70077
[2025] Comparison between a Luminex-based multiplex kit with a sequence-specific oligonucleotide probe and next-generation sequencing for the detection of POLE oncogenic mutations in endometrial cancer
DOI: https://doi.org/10.1007/s00428-025-04204-4
[2025] Guidelines for Endoscopic Surgery in Obstetrics and Gynecology 2024 by Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy: A Secondary Publication Based on the Japanese Edition
DOI: https://doi.org/10.4103/gmit.gmit-d-25-00031
[2025] Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites
DOI: https://doi.org/10.1111/1744-9987.70022
[2025] Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients
DOI: https://doi.org/10.1007/s10147-024-02682-1
[2025] Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm
DOI: https://doi.org/10.3802/jgo.2025.36.e119
[2025] Quality indicators for endometrial cancer care in Japan
DOI: https://doi.org/10.3802/jgo.2025.36.e77
[2024] Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer
DOI: https://doi.org/10.3390/cancers16132384
[2024] Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: a single-center study in Japan
DOI: https://doi.org/10.3802/jgo.2024.35.s2.p85
[2024] Forceps selection for robotic assisted hysterectomy against endometrial cancer
DOI: https://doi.org/10.3802/jgo.2024.35.s2.p36
[2024] A case of transient hyperthyroidism induced by placental site trophoblastic tumor
DOI: https://doi.org/10.1111/jog.16193
[2024] Optimizing the planning process in computed tomography-based image-guided adaptive brachytherapy for cervical cancer using a spreadsheet-based daily dose management system
DOI: https://doi.org/10.1007/s12194-024-00867-x
[2023] Mixed Mesonephric-like Adenocarcinoma, Clear Cell Carcinoma, and Endometrioid Carcinoma Arising from an Endometriotic Cyst
DOI: https://doi.org/10.1177/10668969231213390
[2023] iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer
DOI: https://doi.org/10.1016/j.xcrm.2023.101327
[2023] Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study
DOI: https://doi.org/10.1016/j.brachy.2023.10.003
[2023] Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
DOI: https://doi.org/10.3892/ol.2023.14142
[2023] EP169/#411 Machine learning method for differential diagnosis and prognosis prediction for early-stage uterine sarcoma using preoperative blood biomarker and age
DOI: https://doi.org/10.1136/ijgc-2023-igcs.259
[2023] Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer
DOI: https://doi.org/10.1093/jjco/hyad135
[2023] Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer
DOI: https://doi.org/10.1016/j.ygyno.2023.09.011
[2023] Rare <scp>FGFR</scp> fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
DOI: https://doi.org/10.1002/cam4.6415
[2023] Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study
DOI: https://doi.org/10.1007/s10147-023-02393-z
[2023] MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience
DOI: https://doi.org/10.1016/j.ctro.2023.100659
[2023] Questionnaire survey regarding current status of minimally invasive surgery for endometrial cancer in Japan: A cross‐sectional survey for <scp>JSGOE</scp> members
DOI: https://doi.org/10.1111/jog.15728
[2023] Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
DOI: https://doi.org/10.1038/s41416-023-02203-3
[2023] Cutting-edge Treatment for Gynecological Malignancies
DOI: https://doi.org/10.14789/jmj.jmj22-0044-r
[2023] Rare FGFR fusion genes and subgrouping patients with a poor prognosis using RNA-based classification in cervical cancer
DOI: https://doi.org/10.3802/jgo.2023.34.s1.i03
[2023] Special Program 1: Discussion on Hysterectomy for Uterine Cancer
DOI: https://doi.org/10.5180/jsgoe.39.1_1
[2023] Rare FGFR fusion genes and subgrouping patients with a poor prognosis using RNA-based classification in cervical cancer
DOI: https://doi.org/10.3802/jgo.2023.34.s2.is-023
[2023] Long‐term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report
DOI: https://doi.org/10.1111/jog.15777
[2022] Depressive and anxiety symptoms among Japanese cancer survivors: Japan cancer survivorship research project
DOI: https://doi.org/10.1186/s12885-022-09215-x
[2022] 2022-RA-801-ESGO Challenge to individualize surgical treatment for uterine cancer by intraoperative-prediction of lymph node metastasis using mRNA biomarker and clinical variables
DOI: https://doi.org/10.1136/ijgc-2022-esgo.243
[2022] 2022-RA-794-ESGO Elucidate the mechanism of lymphedema from the analysis of lymphatic function and morphology before and after pelvic lymphadenectomy using indocyanine green fluorescence lymphangiography
DOI: https://doi.org/10.1136/ijgc-2022-esgo.846
[2022] A case of a large solitary fibrous tumor arising from the retroperitoneum resected completely using an intra‐aortic balloon
DOI: https://doi.org/10.1111/jog.15353
[2022] Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer
DOI: https://doi.org/10.3390/jcm11185346
[2022] [A Case Report for Peritoneal Recurrences by Laparoscopic Surgery after Colorectal Cancer Resection].
[2022] Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group
DOI: https://doi.org/10.1016/j.humpath.2022.03.007
[2022] DNA methylation marker to estimate ovarian cancer cell fraction
DOI: https://doi.org/10.1007/s12032-022-01679-y
[2022] EP168/#478 Outcomes of pregnancies and deliveries in patients who underwent fertility preservation surgery for early-stage epithelial ovarian cancer
DOI: https://doi.org/10.1136/ijgc-2022-igcs.259
[2022] DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer
DOI: https://doi.org/10.1016/j.ygyno.2022.10.008
[2022] 2022-RA-1468-ESGO Frequency of MMR deficiency for primary endometrial neuroendocrine carcinoma and its therapeutic outcome in Japan
DOI: https://doi.org/10.1136/ijgc-2022-esgo.326
[2022] 2022-RA-1434-ESGO Palonosetron versus granisetron for prevention of nausea and vomiting during paclitaxel and carboplatin therapy: a pilot study
DOI: https://doi.org/10.1136/ijgc-2022-esgo.453
[2021] A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk‐reducing surgery for hereditary breast and ovarian cancer
DOI: https://doi.org/10.1111/jog.14952
[2021] Management of Early Stage Uterine Adenosarcoma
DOI: https://doi.org/10.1089/gyn.2021.0031
[2021] Predictors of resignation and sick leave after cancer diagnosis among Japanese breast cancer survivors: a cross-sectional study
DOI: https://doi.org/10.1186/s12889-021-10168-2
[2021] Dosimetric predictors of nephrotoxicity in patients receiving extended-field radiation therapy for gynecologic cancer
DOI: https://doi.org/10.1186/s13014-021-01755-z
[2021] Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
DOI: https://doi.org/10.1038/s41598-021-88018-9
[2021] Publisher Correction: Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter
DOI: https://doi.org/10.1038/s41598-021-96196-9
[2021] CT-Guided Pelvic Lymph Nodal Brachytherapy
DOI: https://doi.org/10.3389/fonc.2020.532555

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。

AI 要約（直近 5 年の研究成果）

外部リンク

関連研究室(8 件)

研究成果（85 件）

科研費（0 件）

所属学会・役職（0 件）